Newly Diagnosed Multiple Myeloma Completed Phase 3 Trials for Lenalidomide (DB00480)

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00405756A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.Treatment